Moonshot AI redirects Kimi models toward scientific research
Moonshot AI is shifting the focus of its Kimi language models from coding toward biology, chemistry and pharmaceutical research. Speaking at Web Summit in Lisbon, the company’s international director, Giacomo Ficari, said progress on coding benchmarks was producing diminishing returns. He argued that scientific work requires more capable AI systems than law, finance or programming.
Beijing-based DP Technology is incorporating Kimi K3.1 Pro into its BioMaster research assistant. In one test, the system examined gene data from 3,696 mouse pancreatic cells and identified 100 candidate genes in 90 minutes, compared with an estimated four hours of human work.
The systems remain unable to make fully independent discoveries. On TCSExam, a 100-question theoretical computer science benchmark, leading models generated verifiable proofs but did not solve any open conjectures alone. Similar limits have appeared in the United States: Anthropic’s Claude identified an enzyme system in September, while mathematicians questioned claimed breakthroughs from OpenAI. A June Citi survey of 50 US research leaders found that 72% were already using AI broadly, but only 24% expected it to noticeably improve drug-development success rates.
Written by Sakhanda Wire AI from reporting by The Decoder. Facts, quotes and full context are in the original article below.